BUZZ-Biogen Idec Inc: Says Alzheimer's drug shows promise

martes 2 de diciembre de 2014 10:34 GYT
 

** Biotechnology company's shares up 9 pct at $336.65

** The company says its experimental medicine for Alzheimer's disease showed promise in an early study

** Data strong enough to move into phase 3 trials, company says at Deutsche Bank Biofest

** Up to Monday's close, stock had fallen about 6 pct since Oct. 21, a day before the company reported its Q3 results